Clin2
NCT07712640Possibly a fitRecruiting

Comparing two tablet forms of BGB-58067 and food effect

Healthy Volunteers

Treatments studied

This study tests how two different tablet versions of the study drug BGB-58067 enter the body and how food affects the drug. Healthy volunteers take the drug to help understand the best way to give it in future trials.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • Be 18 to 65 years old
  • Be in good overall health (no major medical conditions)
  • If you are a woman, you must not be able to become pregnant (e.g., after menopause or have had your tubes tied or ovaries removed)
  • If you are a man who can have children, you must use a condom and not donate sperm during the study and for 90 days after the last dose
  • No history of gallstones or gallbladder removal
  • No serious allergies to foods or drugs, including the study drug

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07590102Recruiting· Phase 1
How Body Works With a New Drug and Two Other Medicines

This study tests how a new experimental drug (BGB-58067) moves through your body and how two common medications affect that process. Researchers need healthy volunteers to understand if these drug interactions are safe.

Adelaide, South Australia
NCT07799597Not yet recruiting· Phase 1
Testing a new capsule in healthy adults

This study tests a new medicine called HBW-3220 in healthy adults to see how the body processes it and whether food affects it. Participants will take the capsule and have blood samples taken to measure the medicine's levels.

NCT07811063Not yet recruiting· Phase 1
Testing a new tablet in healthy adults

This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.

Auckland
NCT07629999Recruiting· Phase 1
Safety study of experimental drug BMS-986533 in healthy people

This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.

Lincoln, Nebraska
NCT07283263Recruiting· Phase 1
Safety study of new drug BMS-986521 in healthy volunteers

This study tests a new investigational drug (BMS-986521) in healthy volunteers to see how safe it is and how the body processes it. It helps researchers decide if the drug can be tested in future studies.

Anaheim, California
NCT07226817Recruiting· Phase 1
Testing a new drug and how food affects it

This study tests how a new drug (BMS-986435) is absorbed by the body and whether food changes that. It is for healthy volunteers to help understand the right dose for future patients.

Miami, Florida

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.